# US 2002/0058274 A1 · Rapidly degrading GFP-fusion proteins and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058274 A1
- Document ID: US20020058274A1
- Status: Published application
- Kind: A1
- Application number: 09/931,232
- Filed: 2001-08-15
- Published: 2002-05-16
- Earliest claimed: 1997-10-02
- Assignees: Clontech Laboratories, Inc.
- Inventors: Xianqiang Li; Steve Kain
- Web page: https://patentgrep.com/patent/US20020058274A1

## CPC

- C12N 15/62: DNA sequences coding for fusion proteins
- C07K 14/43595: {from coelenteratae, e.g. medusae}
- C12N 9/88: Lyases (4.)
- C07K 2319/00: Fusion polypeptide
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C07K 2319/71: containing domain for transcriptional activaation, e.g. VP16
- C07K 2319/80: containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K 2319/95: containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Green fluorescent protein (GFP) is widely used as a reporter in determining gene expression and protein localization. The present invention provides fusion proteins with a half life of ten hours or less with several embodiments having half lives of 4 hours or less. Such proteins may be constructed by fusing C-terminal amino acids of the degradation domain of mouse ornithine decarboxylase (MODC), which contains a PEST sequence, to the C-terminal end of an enhanced variant of GFP (EGFP). Fluorescence intensity of the fusion protein in transfected cells is similar to that of EGFP, but the fusion protein, unlike EGFP, is unstable in the presence of cycloheximide. Specific mutations in the MODC region have resulted in mutants with varying half lives, useful for a variety of purposes.

## Claims

### Claim 1

A fusion protein comprising a fluorescent protein, said fusion protein having a half life of no more than about ten hours.

### Claim 2 (depends on 1)

The fusion protein of claim 1, wherein said fluorescent protein is selected from the group consisting of EGFP, ECFP and EYFP.

### Claim 3 (depends on 2)

The fusion protein of claim 2, wherein said fusion protein comprises a PEST sequence-containing portion of a C-terminus of murine ornithine decarboxylase (MODC) fused to said fluorescent protein.

### Claim 4 (depends on 3)

The fusion protein of claim 3, wherein said PEST sequence-containing portion of said C-terminus of murine ornithine decarboxylase comprises an amino acid selected from the group consisting of MODC376-461, MODC376-456, MODC422-461, P426A/P427A, P438A, E428A/E430A/E431A, E444A, S440A, S445A, T436A, D433A/D434A and D448A.

### Claim 5 (depends on 3)

The fusion protein of claim 3, wherein said protein has the sequence shown in SEQ ID No. 1.

### Claim 6 (depends on 1)

An isolated DNA molecule encoding the fusion protein of claim 1.

### Claim 7 (depends on 6)

The DNA of claim 6, wherein said DNA encodes a fusion protein wherein said fluorescent protein is selected from the group consisting of EGFP, ECFP and EYFP.

### Claim 8 (depends on 7)

The DNA of claim 7, wherein said DNA encodes a fusion protein comprising a PEST sequence-containing portion of a C-terminus of murine ornithine decarboxylase (MODC) fused to the fluorescent protein.

### Claim 9 (depends on 8)

The DNA of claim 8, wherein said PEST sequence-containing portion of a C-terminus of murine ornithine decarboxylase is selected from the group consisting of MODC376-461, MODC376-456, MODC422 461, P426A/P427A, P438A, E428A/E430A/E431A, E444A, S440A, S445A, T436A, D433A/D434A and D448A.

### Claim 10 (depends on 8)

The isolated DNA of claim 8, having the sequence shown in SEQ ID No. 2.

### Claim 11 (depends on 6)

A vector capable of expressing the isolated DNA molecule of claim 6.

### Claim 12 (depends on 11)

The vector of claim 11, wherein said vector comprises an inducible promoter.

### Claim 13 (depends on 10)

A vector capable of expressing the isolated DNA molecule of claim 10.

### Claim 14 (depends on 13)

The vector of claim 13, wherein said vector comprises an inducible promoter.

### Claim 15 (depends on 14)

The vector of claim 14, wherein said promoter is tetracycline-inducible.

### Claim 16 (depends on 11)

A method of producing a stable cell line that expresses a fluorescent protein comprising the step of transfecting cells with the vector of claim 11.

### Claim 17 (depends on 16)

The stable cell line produced by the method of claim 16.

### Claim 18

A method of assaying activation or deactivation of transcriptional or translational elements with a transient fluorescent reporter protein, comprising the steps of:
transfecting cells with an expression vector comprising a fluorescent protein fusion protein having a half life of no more than about ten hours, wherein the fusion protein is under the influence of the promoter, transcriptional or translational element; and
detecting the presence, absence or amount of fluorescence in said cells.

### Claim 19 (depends on 18)

The method of claim 18, wherein the amount of fluorescence present in the cell is a measure of the fluorescent protein that is being expressed.

### Claim 20

A method of assaying activation or deactivation of promoters or other transcriptional or translational elements with a transient fluorescent protein reporter protein, comprising the steps of:
transfecting cells with an expression vector comprising a fluorescent fusion protein having a half life of no more than about ten hours, wherein the fluorescent fusion protein is under an influence of said promoter, transcriptional or translational element;
treating said transfected cells with a compound of interest; and
detecting a change in fluorescence upon treatment of the cells with said compound of interest so as to assay the effect of said compound of interest on said activation or deactivation of said transcription or translation elements.

### Claim 21 (depends on 1)

A method of studying cell lineage, comprising the steps of:
transfecting undifferentiated cells with a vector expressing the destabilized fusion protein of claim 1;
growing said undifferentiated cells under conditions in which the undifferentiated cells become differentiated cells; and
detecting an absence, presence or location of fluorescence in the differentiated cells.

### Claim 22 (depends on 1)

A method of using a fusion protein of claim 1 in cell localization studies, comprising the steps of:
transfecting cells with an expression vector comprising a GFP fusion protein having a half life of no more than ten hours, wherein the fusion protein is linked to a putative cell localization element;
growing the cell; and
detecting a location of fluorescence in the cells.
